HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers

4h ago, source:

NEW YORK and VIENNA, Austria, April 24, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class ...

Hookipa Received FDA Clearance For HB-700 For Treatment Of KRAS-Mutated Cancers

2h ago, source:

Hookipa Pharma Inc. (HOOK) announced on Wednesday that it has received FDA clearance for its Investigational New Drug or IND ...

Why Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday?

1h ago, source:

HOOKIPA Pharma secures FDA clearance for its innovative HB-700 therapeutic vaccine targeting KRAS-mutated cancers. Learn about its broad impact on lung, colorectal, and pancreatic cancers, achieving ...

HOOK HOOKIPA Pharma Inc.

3d ago, source: Seeking Alpha

HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company’s ...

Hookipa Pharma: 04/25/24 Update Should Be The First Of Several Positive Catalysts

1d ago, source:

Hookipa Pharma's positive data could push shares up 3-5x while negative news could cut the stock in half or worse. Check out ...

HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to Registration

14d ago, source:

HOOKIPA announces alignment with FDA on pivotal trial design and protocol for HB-200 in combination with pembrolizumabHB-200 ...

HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

7d ago, source: Yahoo Finance

NEW YORK and VIENNA, Austria, April 16, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company ...

HOOKIPA Pharma Inc HOOK

13d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to Registration

14d ago, source: Business Insider

8:00 a.m. ET Webcast Registration Dial-in Registration About HOOKIPA HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies ...

HOOKIPA Pharma Inc.

27d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...